Pulmonary hypertension alters soluble guanylate cyclase activity and expression in pulmonary arteries isolated from fetal lambs

被引:0
|
作者
Tzao, C
Nickerson, PA
Russell, JA
Gugino, SF
Steinhorn, RH
机构
[1] SUNY Buffalo, Dept Pathol, Buffalo, NY 14260 USA
[2] SUNY Buffalo, Dept Physiol, Buffalo, NY 14260 USA
[3] SUNY Buffalo, Dept Pediat, Buffalo, NY 14260 USA
[4] Northwestern Univ, Dept Pediat, Chicago, IL 60611 USA
关键词
nitric oxide; pulmonary hypertension; pulmonary artery; lung; nitric oxide synthase; cyclic guanosine monophosphate; soluble guanylate cyclase; animal studies;
D O I
10.1002/1099-0496(200102)31:2<97::AID-PPUL1016>3.0.CO;2-K
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The nitric oxide (NO)-guanosine 3',5'-cyclic monophosphate (cGMP) signaling pathway plays an important role in the pulmonary vascular transition at birth. We studied pulmonary arteries and veins isolated from normal late-gestation fetal lambs and from fetal lambs with persistent pulmonary hypertension (PPHN) following prenatal ligation of the ductus arteriosus. We additionally used double immunolabeling and immunoblot analysis to determine relative vascular contents of endothelial nitric oxide synthase (NOS-III) and soluble guanylate cyclase (sGC). Cyclic GMP content and sGC activity were significantly lower in arteries from hypertensive lambs than controls. A rank order for contents of both soluble guanylate cyclase and NOS-III was observed by both immunolabeling and immunoblotting: Control vein = Hypertensive vein > Control artery > Hypertensive artery. Our data demonstrate that the relative expression of sGC correlates well with the relative expression of NOS-III, and indicate the potential importance of soluble guanylate cyclase in the regulation of the perinatal pulmonary circulation. These data may help us understand vascular mechanisms producing PPHN, as well as patterns of response to exogenous NO. Pediatr Pulmonol. 2001; 31:97-105, (C) 2001 Wiley-Liss, Inc.
引用
收藏
页码:97 / 105
页数:9
相关论文
共 50 条
  • [1] Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension
    Schermuly, R. T.
    Stasch, J-P.
    Pullamsettl, S. S.
    Middendorff, R.
    Mueller, D.
    Schlueter, K-D.
    Dingenclorf, A.
    Hackemack, S.
    Kolosionek, E.
    Kaulen, C.
    Dumitrascu, R.
    Weissmann, N.
    Mittendorf, J.
    Klepetko, W.
    Seeger, W.
    Ghofrani, H. A.
    Grirnminger, F.
    EUROPEAN RESPIRATORY JOURNAL, 2008, 32 (04) : 881 - 891
  • [2] DISRUPTION OF CGMP PRODUCTION IN PULMONARY-ARTERIES ISOLATED FROM FETAL LAMBS WITH PULMONARY-HYPERTENSION
    STEINHORN, RH
    RUSSELL, JA
    MORIN, FC
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1995, 268 (04): : H1483 - H1489
  • [3] Soluble guanylate cyclase as a therapeutic target in pulmonary hypertension
    Eygenov, Olee V.
    NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2010, 22 : S32 - S32
  • [4] Targeting soluble guanylate cyclase for the treatment of pulmonary hypertension
    Lasker, George F.
    Maley, Jason H.
    Pankey, Edward A.
    Kadowitz, Philip J.
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2011, 5 (02) : 153 - 161
  • [5] Soluble Guanylate Cyclase (sGC) is Decreased Within Pulmonary Arterial Smooth Muscle of Fetal Lambs with Experimentally-Induced Pulmonary Hypertension.• 1486
    Christopher A. D'Angelis
    Robin H. Steinhorn
    Arthur Tzao
    Frederick C. Morin
    Peter A. Nickerson
    Pediatric Research, 1997, 41 (Suppl 4) : 250 - 250
  • [6] Riociguat: a soluble guanylate cyclase stimulator for the treatment of pulmonary hypertension
    Lian, Tian-Yu
    Jiang, Xin
    Jing, Zhi-Cheng
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 1195 - 1207
  • [7] RIOCIGUAT Soluble Guanylate Cyclase Stimulator Treatment of Pulmonary Hypertension
    Mulligan, C.
    DRUGS OF THE FUTURE, 2009, 34 (06) : 468 - 475
  • [8] Increased hydrogen peroxide downregulates soluble guanylate cyclase in the lungs of lambs with persistent pulmonary hypertension of the newborn
    Wedgwood, S
    Steinhorn, RH
    Bunderson, M
    Wilham, J
    Lakshminrusimha, S
    Brennan, LA
    Black, SM
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2005, 289 (04) : L660 - L666
  • [9] Heterogeneous distribution of soluble guanylate cyclase in the pulmonary vasculature of the fetal lamb
    D'Angelis, CA
    Nickerson, PA
    Steinhorn, RH
    Morin, FC
    ANATOMICAL RECORD, 1998, 250 (01): : 62 - 69
  • [10] Soluble Guanylate Cyclase: A New Therapeutic Target for Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
    Dasgupta, A.
    Bowman, L.
    D'Arsigny, C. L.
    Archer, S. L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 (01) : 88 - 102